Bing

SEARCH HISTORY

Investors in CTI BioPharma Corp (CTIC) saw new options begin trading this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CTIC options chain for the …
The Street · 6/23/2015
CTI BioPharma Corp (NASDAQ:CTIC) EVP Jack W. Singer sold 15,000 shares of CTI BioPharma Corp stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $2.07, for a total value of $31,050.00. Following the sale, the ...
Ticker Report · 6/27/2015
Previous Insider Selling: Jack W. Singer Sells 15,000 Shares of CTI BioPharma Corp Stock (CTIC) Next » Insider Selling: Igor Levental Sells 60,000 Shares of Novacopper Stock (NCQ)
wkrb13.com · 6/27/2015
More from Bing News
Shares of CTI BioPharma Corp. (NASDAQ:CTIC) slipped more than 10% in trade today after the company issued a press release yesterday, in which it announced it will put up its Series 21 Preferred Stock in an underwritten public offering. The company is ...
bidnessetc.com · 11/7/2014
CTI BioPharma Corp. (CTIC - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The upside came after the company released data from a Phase 3 registration-directed trial that examined pacritinib to ...
ZACKS · 6/2/2015
As of late, it has definitely been a great time to be an investor in CTI BioPharma Corp ( CTIC). The stock has moved higher by 17.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable ...
NASDAQ · 6/2/2015
CTI BioPharma Corp. (CTIC) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The upside came after the company released data from a Phase 3 registration-directed trial that examined pacritinib to treat myleofibrosis.
Yahoo Finance · 6/2/2015
Research analysts at Roth Capital set a $4.50 target price on shares of CTI BioPharma Corp (NASDAQ:CTIC) stock in a report released on Monday. The firm currently has a a “buy” rating on the biopharmaceutical company’s stock. Roth Capital’s …
sleekmoney.com · 6/1/2015
Watch the video to learn about the probability of CTI BioPharma Corp. (CTIC) Chart Signal as of Jun 20, 2015 This free program will calculate the probabilities of CTI BioPharma Corp. (CTIC) stock chart
Hot Stocked · 1/26/2009
CTI BioPharma Corp (NASDAQ:CTIC)‘s stock had its “fair value” rating restated by equities researchers at Janney Montgomery Scott in a research report issued on Monday. They currently have a $1.94 price objective on the biopharmaceutical …
Mideast Times · 6/2/2015